Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Leading Players Driving Innovation in the Circadian Rhythm Sleep Treatment Market Key players in that circadian rhythm sleep treatment market are Vanda Pharmaceuticals, Inc., Akeda Pharmaceutical ...

Leading Players Driving Innovation in the Circadian Rhythm Sleep Treatment Market Key players in that circadian rhythm sleep treatment market are Vanda Pharmaceuticals, Inc., Akeda Pharmaceutical ...

Begin your TipRanks Premium journey today. Vanda (VNDA) Company Description: Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs.

NASDAQ:VNDA opened at $4.36 on Monday. The company has a market cap of $254.23 million, a P/E ratio of -15.57 and a beta of 0.77. Vanda Pharmaceuticals has a 52-week low of $3.46 and a 52-week ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Also Read: Over 200% Stock Upside – Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst In September, the FDA issued a Complete Response Letter to the company.

After a series of strongly worded letters—one of which was addressed directly to Commissioner Robert Califf—the FDA has publicly laid out its reasoning for rejecting Vanda Pharmaceuticals’ ...